NasdaqCM - Delayed Quote USD
Lipella Pharmaceuticals Inc. (LIPO)
2.3950
+0.1250
+(5.51%)
At close: April 22 at 4:00:00 PM EDT
2.3500
-0.05
(-1.88%)
Pre-Market: 8:48:58 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,950.7470
-3,950.7470
-3,150.1720
-1,831.1610
-989.2710
Investing Cash Flow
--
--
-14.4340
300.5460
-300.5460
Financing Cash Flow
2,841.8720
2,841.8720
1,336.6010
5,238.5300
2,096.9090
End Cash Position
2,184.8630
2,184.8630
3,293.7380
5,121.7430
1,413.8280
Interest Paid Supplemental Data
11.9080
11.9080
11.3580
--
--
Capital Expenditure
--
--
-14.4340
--
--
Issuance of Capital Stock
2,841.8720
2,841.8720
--
4,963.5300
2,096.9090
Issuance of Debt
--
--
--
275
--
Repayment of Debt
--
--
-275
--
--
Free Cash Flow
-3,950.7470
-3,950.7470
-3,164.6060
-1,831.1610
-989.2710
12/31/2021 - 12/19/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OBIO Orchestra BioMed Holdings, Inc.
2.8600
+0.70%
MLEC Moolec Science SA
0.6801
-1.15%
TNFA TNF Pharmaceuticals, Inc.
0.1779
+3.73%
MTVA MetaVia Inc.
0.7500
+1.35%
OSTX OS Therapies Incorporated
1.5200
+2.01%
CMND Clearmind Medicine Inc.
1.0000
-4.76%
SLGL Sol-Gel Technologies Ltd.
0.5970
+2.05%
AVTE Aerovate Therapeutics, Inc.
2.7600
-0.36%
GLTO Galecto, Inc.
2.6800
+10.74%
BDRX Biodexa Pharmaceuticals Plc
1.4000
+1.45%